Genetic analysis of the influence of pertussis toxin on experimental allergic encephalomyelitis susceptibility: An environmental agent can override genetic checkpoints

Journal of Immunology

Volumn 164, Issue 6, 2000, Pages 3420-3425

  Blankenhorn, Elizabeth P ^a   Butterfield, Russell J ^b   Rigby, Robert ^a   Cort, Laura ^a   Giambrone, Dana ^a   McDermott, Paul ^a   McEntee, Kay ^a   Solowski, Nancy ^a   Meeker, Nathan D ^b   Zachary, James F ^b   Doerge, Rebecca W ^c   Teuscher, Cory ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS TOXIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DEMYELINATION; DRUG EFFECT; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; MACROPHAGE ACTIVATION; MEDIATOR RELEASE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0034654320     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.6.3420     Document Type: Article

References (49)

1. Munoz, J. J. (1985). Biological activities of pertussigen (pertussis toxin). In Pertussis Toxin R. C. Sekura, J. Moss, and M. Vaughan, eds. Academic Press, Orlando, FL, pp 1-18.
2. Brocke, S., K. Gijbels, and L. Steinman. 1994. Experimental autoimmune encephalomyelitis in the mouse. In Autoimmune Disease Models. I. R. Cohen and A. Miller, eds. Academic Press, San Diego, pp. 1-14.
3. Tung, K. S. K., O. Taguchi, and C. Tester. 1994. Testicular and ovarian autoimmune diseases. In Autoimmune Disease Models. I. R. Cohen and A. Miller, eds. Academic Press, San Diego, pp. 267-290.
4. Mochizuki, M., J. Charley, T. Kuwabara, R. B. Nussenblatt, and I. Gery. 1983. Involvement of the pineal gland in rats with experimental autoimmune uveitis. Invest. Opthalmol. Vis. Sci. 24:1333.
5. Munoz, J. J. 1988. Action of pertussigen (pertussis toxin) on the host immune system. In Pathogenesis and Immunity in Pertussis. A. C. Wardlaw and R. Partoin, eds. Wiley, New York. pp. 173-187.
6. Linthicum, S. 1982. Development of acute autoimmune encephalomyelitis in mice: factors regulating the effector phase of the disease. Immunobiology 162: 211.
7. Linthicum, D. S., J. J. Munoz, and A. Blaskett. 1982. Acute experimental autoimmune encephalomyelitis in mice. 1. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cell. Immunol. 73:299.
8. Amiel, S. A. 1976. The effects of Bordetella pertussis vaccine on cerebral vascular permeability. Br. J. Exp. Pathol. 57:653.
9. Brabb, T., A. W. Goldrath, P. von Dassow, A. Paez, H. D. Liggitt, and J. Goverman. 1997. Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis. J. Immunol. 159:497.
10. Bergman, R. K., J. J. Munoz, and J. L. Portis. 1978. Vascular permeability changes in the central nervous system of rats with hyperacute experimental allergic encephalomyelitis induced with the aid of a substance from Bordetella pertussis. Infect. Immun. 21:627.
11. Person, P. L., R. Korngold, and C. Teuscher 1992. Pertussis toxin-induced lymphocytosis is associated with alterations in thymocyte subpopulations. J. Immunol. 148:1506.
12. Sudweeks, J. D., J. A. Todd, E. P. Blankenhorn, B. B. Wardell, S. R. Woodward, N. D. Meeker, S. S. Estes, and C. Teuscher. 1993. Locus controlling Bordetella pertussis-induced histamine sensitization (Bphs), an autoimmune disease-susceptibility gene, maps distal to T-cell receptor-chain on mouse chromosome 6. Proc. Natl. Acad. Sci. USA 90:3700.
13. Linthicum, D. S., and J. A. Frelinger. 1982. Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitizalion genes. J. Exp. Med. 156:31.
14. Teuscher, C. 1985. Experimental allergic orchitis in mice. H. Association of disease susceptibility with the locus controlling Bordetella pertussis-induced sensitivity to histamine. Immunogenetics 22:417.
15. Meeker, N. D., A. N. Stafford, J. K. Lunceford, P. Avner, R. Z. Ma, and C. Teuscher. 1999. Physical mapping of the autoimmune disease susceptibility locus, Bphs: co-localization with a cluster of genes from the tnf receptor superfamily on mouse chromosome 6. Mamm. Genome. 10:858.
16. Butterfield, R. J., J. D. Sudweeks, E. P. Blankenhorn, R. Korngold, J. C. Marini, J, A. Todd, R. J. Roper, and C. Teuscher. 1998. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice, J. Immunol. 161:1860.
17. Kohno S., J. A. Munoz, T. M. Williams, C. Teuscher, C. C. Bernard, and K. S. Tung. 1983. Immunopathology of murine experimental allergic orchitis. J. Immunol. 130:2675.
18. Brown, A. M., and D. E. McFarlin. 1981. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab. Invest. 45:278.
19. Brown, A., D. E. McFarlin, and C. S. Raine. 1982. Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Lab. Invest. 46:171.
20. Manly, K. 1999. http://mcbio.med.buffalo.edu.
21. Basten, C. J., B. S. Weir, and Z.-B. Zeng. 1997. QTL Cartographer: A Reference Manual and Tutorial for QTL Mapping. Department of Statistics. North Carolina State University, Raleigh, NC.
22. Churchill, G. A., and R. W. Doerge. 1994. Empirical thresholds for quantitative trait mapping. Genetics 138:963.
23. SAS Institute. 1989. SST/STAT User's Guide, version 6, 4th Ed., Vol. 2, SAS Institute, Cary, NC.
24. Roper, R. J., J. S. Griffith, C. R. Lyttle, R. W. Doerge, A. W. McNabb, R. E. Broadbent, and C. Teuscher. 1999. Interacting quantitative trait loci control phenotypic variation in murine estradiol-regulated responses. Endocrinology 140:556.
25. Bulterfield, R. J., E. P. Blankenhorn, R. J. Roper, J. F. Zachary, R. W. Doerge, J. Sudweeks, J. Rose, and C. Teuscher. 1999. Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): relapsing/remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct. J. Immunol. 162:3096.
26. Munoz, J. J., and I. R Mackay. 1984. Production of experimental allergic encephalomyelitis with the aid of pertussigen in mouse strains considered genetically resistant. J. Neuroimmunol. 7:91.
27. Teuscher, C., W. F. Hickey, C. M. Grafer, and K. S. Tung. 1998. A common immunoregulatory locus controls susceptibility to actively induced experimental allergic encephalomyelitis and experimental allergic orchitis in BALB/c mice. J. Immunol. 160:2751.
28. Spangrude, G. J., B. A. Braaten, and R. A. Daynes. 1984. Molecular mechanisms of lymphocyte extravasation. I. Studies of two selective inhibitors of lymphocyte recirculation. J. Immunol. 132:354.
29. Spangrude, G. J., F. Sacchi, H. R. Hill, D. E.Van Epps, and R. A. Daynes. 1985. Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin. J. Immunol. 135:4135.
30. Kong, A. S., and S. I. Morse. 1977. The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes. 1. Proliferative response. J. Exp. Med. 145:151.
31. Sewell, W. A., J. J. Munoz, R. Scollay, and M. A. Vadas. 1984. Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen. Immunology 133:1716.
32. Sewell, W. A., J. J. Munoz, and M. A. Vadas. 1983. Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice. J. Exp. Med. 157:2087.
33. Sewell, W. A., P. A. de Moerloose, J. L. McKimm-Breschkin, and A. Vadas. 1986. Pertussigen enhances antigen-driven Interferon-γ production by sensitized lymphoid cells. Cell. Immunol. 97:238.
34. Vistica, B. P., C. G. McAllister, R. D. Sekura, J. N. Ihle, and I. Gery. 1986. Dual effects of pertussis toxin on lymphoid cells in culture. Cell. Immunol. 101:232.
35. Ryan, M., L. McCarthy, R. Rappuoli, B. P. Mahon, and K. H. Mills. 1998. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. Int. Immunol. 10:651.
36. Kamradt, T., P. D. Soloway, D. L. Petkins, and M. L. Gefter. 1991. Pertussis toxin prevents the induction of peripheral T cell anergy and enhances the T cell response to an encephalitogenic peptide of myelin basic protein. J. Immunol. 147:3296.
37. Suzuki, G., H. Sawa, Y. Kobayashi, Y. Nakata, K. Nakagawa, A. Uzawa, H. Sakiyama, S. Kakinuma, K. Iwabuchi, and K. Nagashima. 1999. Pertussis toxin-sensitive signal controls the trafficking of thymocytes across the corticomedullary junction in the thymus. J. Immunol. 162:5981.
38. Teuscher, C., R. J. Butterfield, R. Z. Ma, J. F. Zachary, R. W. Doerge, and E. P. Blankenhorn. 1999. Sequence polymorphisms in the chemokines Scyal (TCA3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis. J. Immunol. 163: 2262.
39. Butzer, U., H. Weidenbach, S. Gansauge, F. Gansauge, H. G. Beger, and A. K. Nussler. 1993. Increased oxidative stress in the RAW 264. 7 macrophage cell line is partially mediated via the S-nitrosothiol-induced inhibition of glutathione reductase. Infect. Dis. 167:762.
40. Nichols, E. A., and F. H. Ruddle. 1975. Polymorphism and linkage of glutathione reductase in Mus musculus. Biochem. Genet. 13:323.
41. Juan, T. S., I. K. McNiece, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, and F. A. Fletcher. 1996. Molecular characterization of mouse and rat CPP32β gene encoding a cysteine protease resembling interleukin-1β converting enzyme and CED-3. Oncogene 13:749.
42. Bonetti, B., J. Pohl, Y. L. Gao, and C. S. Raine. 1997. Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J. Immunol. 159:5733.
43. Pender, M. P. 1999. Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance. Immunol. Cell Biol. 77:216.
44. Sabelko-Downes, K. A., A. H. Cross, and J. H. Russell. 1999. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J. Exp. Med. 189:1195.
45. Aaltonen, J., and P. Bjorses. 1999. Cloning of the APECED gene provides new insight into human autoimmunity. Ann. Med. 31:111.
46. Baker, D., O. A. Rosenwasser, J. K. O'Neill, and J. L. Turk. 1995. Genetic analysis of experimental allergic encephalomyelitis in mice. J. Immunol. 155: 4046.
47. Brahic, M., and J. F. Bureau. 1998. Genetics of susceptibility to Theiler's virus infection. BioEssays 20:627.
48. Bihl F., M. Brahic, and J. F. Bureau. 1999. Two loci, Tmevp2 and Tmevp3, located on the telomeric region of chromosome 10, control the persistence of Theiler's virus in the central nervous system of mice. Genetics 152:385.
49. Bihl, F., C. Pena-Rossi, J. L. Guenet, M. Brahic, and J. F. Bureau. 1997. The shiverer mutation affects the persistence of Theiler's virus in the central nervous system. J. Virol. 71:5025.